Pila Pharma AB (publ)

OM:PILA Stock Report

Market Cap: SEK 75.7m

Pila Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OM:PILA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Nov 24BuySEK 99,800Dorte GramIndividual20,000SEK 4.99

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of PILA?
Owner TypeNumber of SharesOwnership Percentage
Institutions3,933,85714.5%
Individual Insiders6,231,61823%
General Public7,578,34627.9%
Private Companies9,382,80234.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 17 shareholders own 72.06% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
19.2%
Dorte Gram
5,215,086SEK 14.6m0.38%no data
18.4%
Virala Oy Ab
5,000,000SEK 14.0m0%no data
14.6%
Vimpu Intressenter AB
3,964,502SEK 11.1m0%no data
3.43%
Almi Invest AB
930,500SEK 2.6m0%11.72%
3.25%
Goldman Sachs Group, Investment Banking and Securities Investments
882,653SEK 2.5m36.4%no data
1.99%
UBS Asset Management AG
540,260SEK 1.5m0%no data
1.82%
Peter Odsgard
495,000SEK 1.4m0%no data
1.65%
JPMorgan Chase & Co, Private Banking and Investment Banking Investments
446,421SEK 1.2m0.26%no data
1.61%
Sebastian Clausin
436,745SEK 1.2m0%no data
1.58%
BNY Asset Management
429,935SEK 1.2m-5.33%no data
1.54%
Co2 Balance A/S
418,300SEK 1.2m0%no data
1.31%
Avanza Fonder AB
355,460SEK 991.7k0%no data
1.27%
Nordnet Pensionsförsäkring Ab, Asset Management Arm
345,146SEK 963.0k-7.98%0.02%
0.12%
Richard Busellato
33,457SEK 93.3k0%no data
0.11%
Elna Astrom
30,000SEK 83.7k0%no data
0.079%
Fredrik Buch
21,330SEK 59.5k0%no data
0.013%
FCG Fonder AB
3,482SEK 9.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/15 05:41
End of Day Share Price 2025/05/15 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pila Pharma AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Filip EinarssonRedeye